Literature DB >> 35201469

Does circulating progesterone mediate the associations of single nucleotide polymorphisms in progesterone receptor (PGR)-related genes with mammographic breast density in premenopausal women?

Jingqin Luo1,2, Adetunji T Toriola3,4, Favour A Akinjiyan5, Yunan Han1,6.   

Abstract

Progesterone is a proliferative hormone in the breast but the associations of genetic variations in progesterone-regulated pathways with mammographic breast density (MD) in premenopausal women and whether these associations are mediated through circulating progesterone are not clearly defined. We, therefore, investigated these associations in 364 premenopausal women with a median age of 44 years. We sequenced 179 progesterone receptor (PGR)-related single nucleotide polymorphisms (SNPs). We measured volumetric percent density (VPD) and non-dense volume (NDV) using Volpara. Linear regression models were fit on circulating progesterone or VPD/NDV separately. We performed mediation analysis to evaluate whether the effect of a SNP on VPD/NDV is mediated through circulating progesterone. All analyses were adjusted for confounders, phase of menstrual cycle and the Benjamini-Hochberg false discovery (FDR) adjusted p-value was applied to correct for multiple testing. In multivariable analyses, only PGR rs657516 had a direct effect on VPD (averaged direct effect estimate = - 0.20, 95%CI = - 0.38 ~ - 0.04, p-value = 0.02) but this was not statistically significant after FDR correction and the effect was not mediated by circulating progesterone (mediation effect averaged across the two genotypes = 0.01, 95%CI = - 0.02 ~ 0.03, p-value = 0.70). Five SNPs (PGR rs11571241, rs11571239, rs1824128, rs11571150, PGRMC1 rs41294894) were associated with circulating progesterone but these were not statistically significant after FDR correction. SNPs in PGR-related genes were not associated with VPD, NDV and circulating progesterone did not mediate the associations, suggesting that the effects, if any, of these SNPs on MD are independent of circulating progesterone.
© 2021. The Author(s).

Entities:  

Keywords:  Breast; Genetics; Mammographic breast density; Premenopausal; Progesterone; SNPs

Year:  2021        PMID: 35201469     DOI: 10.1007/s12672-021-00438-1

Source DB:  PubMed          Journal:  Discov Oncol        ISSN: 2730-6011


  36 in total

1.  A paracrine role for the epithelial progesterone receptor in mammary gland development.

Authors:  C Brisken; S Park; T Vass; J P Lydon; B W O'Malley; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

2.  Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.

Authors:  Anne McTiernan; Christopher F Martin; Jennifer D Peck; Aaron K Aragaki; Rowan T Chlebowski; Etta D Pisano; C Y Wang; Robert L Brunner; Karen C Johnson; JoAnn E Manson; Cora E Lewis; Jane M Kotchen; Barbara S Hulka
Journal:  J Natl Cancer Inst       Date:  2005-09-21       Impact factor: 13.506

3.  Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials.

Authors:  Rowan T Chlebowski; Thomas E Rohan; JoAnn E Manson; Aaron K Aragaki; Andrew Kaunitz; Marcia L Stefanick; Michael S Simon; Karen C Johnson; Jean Wactawski-Wende; Mary J O'Sullivan; Lucile L Adams-Campbell; Rami Nassir; Lawrence S Lessin; Ross L Prentice
Journal:  JAMA Oncol       Date:  2015-06       Impact factor: 31.777

4.  Breast patterns as an index of risk for developing breast cancer.

Authors:  J N Wolfe
Journal:  AJR Am J Roentgenol       Date:  1976-06       Impact factor: 3.959

5.  Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.

Authors:  Naile Bolca Topal; Serdal Ayhan; Ugur Topal; Tufan Bilgin
Journal:  J Obstet Gynaecol Res       Date:  2006-06       Impact factor: 1.730

6.  Heritability of mammographic density, a risk factor for breast cancer.

Authors:  Norman F Boyd; Gillian S Dite; Jennifer Stone; Anoma Gunasekara; Dallas R English; Margaret R E McCredie; Graham G Giles; David Tritchler; Anna Chiarelli; Martin J Yaffe; John L Hopper
Journal:  N Engl J Med       Date:  2002-09-19       Impact factor: 91.245

7.  Breast cancer risk factors and mammographic density among high-risk women in urban China.

Authors:  Hyuna Sung; Jiansong Ren; Jing Li; Min Dai; Xiaohong R Yang; Jie He; Ruth M Pfeiffer; Yong Wang; Jennifer L Guida; Yi Fang; Jufang Shi; Kai Zhang; Ni Li; Shen Wang; Luopei Wei; Nan Hu; Gretchen L Gierach
Journal:  NPJ Breast Cancer       Date:  2018-02-06

8.  Hormone replacement therapy and mammographic density: a systematic literature review.

Authors:  Shadi Azam; Katja Kemp Jacobsen; Arja R Aro; Elsebeth Lynge; Zorana Jovanovic Andersen
Journal:  Breast Cancer Res Treat       Date:  2020-06-22       Impact factor: 4.872

Review 9.  Mammographic density phenotypes and risk of breast cancer: a meta-analysis.

Authors:  Andreas Pettersson; Rebecca E Graff; Giske Ursin; Isabel Dos Santos Silva; Valerie McCormack; Laura Baglietto; Celine Vachon; Marije F Bakker; Graham G Giles; Kee Seng Chia; Kamila Czene; Louise Eriksson; Per Hall; Mikael Hartman; Ruth M L Warren; Greg Hislop; Anna M Chiarelli; John L Hopper; Kavitha Krishnan; Jingmei Li; Qing Li; Ian Pagano; Bernard A Rosner; Chia Siong Wong; Christopher Scott; Jennifer Stone; Gertraud Maskarinec; Norman F Boyd; Carla H van Gils; Rulla M Tamimi
Journal:  J Natl Cancer Inst       Date:  2014-05-10       Impact factor: 13.506

10.  Progesterone regulates the proliferation of breast cancer cells - in vitro evidence.

Authors:  Juberiya M Azeez; Hima Sithul; Indhu Hariharan; Sreeja Sreekumar; Jem Prabhakar; Sreeharshan Sreeja; Madhavan Radhakrishna Pillai
Journal:  Drug Des Devel Ther       Date:  2015-11-09       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.